PRINCETON, N.J., Nov. 4, 2010 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, today announced that more than twenty posters will be presented by Company scientists at the 2010 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition being held from November 14 -18 at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
Leading PharmaNet's delegation at AAPS will be Riaz Bandali, President, Early Stage Development, who is responsible for the Company's Phase I clinics and bioanalytical laboratories. Mr. Bandali and other PharmaNet experts will be at booth 1519 to discuss the Company's industry-leading bioanalytical capacity, the Company's offerings of more than 1000 validated methods and its custom method development and validation, bioanalytical mass spectrometry, and immunochemistry services.
Attendees are invited to attend the PharmaNet poster presentations:
Monday, November 15, 2010, 13:00 – 17:00 Exhibit Hall B1Quantitative Determination of Alendronate Sodium in Human Plasma Using a Validated LCMSMS Method: Application to Clinical Pharmacokinetic Studies, (M1500)
Tuesday, November 16, 2010, 8:00 – 12:00 Exhibit Hall B1Leuprolide: A Sensitive LCMSMS Method for the Analysis of a Large Molecule, (T2245)
Development and Validation of a Dried Blood Spot Assay for the Determination of Midazolam in Human Whole Blood by LCMSMS, (T2253)
Importance of Incurred Samples Reanalysis to Assess the Reproducibility of Exemestane Assay, (T2288)
Specific, Selective and Robust Determination of Quaternary Ammonium Compound Scopolamine N-Butyl in Human Plasma by LCMSMS, (T2252)
Innovative Determination of Unbound Docetaxel in Human Plasma using a Filtration Device, (T227
|SOURCE PharmaNet Development Group, Inc.|
Copyright©2010 PR Newswire.
All rights reserved